US 11033601
Selective inhibition of V1b for treating fatty liver
granted A61KA61K31/404A61K31/5377
Quick answer
US patent 11033601 (Selective inhibition of V1b for treating fatty liver) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/404, A61K31/5377, A61K38/095, A61K45/06